ITALY PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) MARKET ANALYSIS

Italy Peptide Receptor Radionuclide Therapy (PRRT) Market, by Drug Type (Lutetium (Lu-177)-based, and Yttrium (Y-90)-based), by Indication (Gastroenteropancreatic Neuroendocrine Tumor), and by Distribution Channel (Hospital Pharmacies and Retail Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Published In : Dec 2019
Code : CMI3139
Pages :63
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Increasing incidence of pancreatic cancer in Europe region is expected to support growth of the market over the forecast period. For instance, according to United European Gastroenterology report in Europe region, there was a 5% increase in the number of pancreatic cancer cases during the years 1990 to 2016.